Ovarian cancer may start in the fallopian tubes, not the ovaries. Explore the latest research and prevention strategies with Jayanthi Lea, M.D., Division Chief of Gynecologic Oncology at UT Southwestern.
ACOG recommends vaginal hysterectomy if patients need one, but only 25% are done that way. See how vNOTES, an advanced approach, could offer more patients less invasive surgery.
PARP-1 inhibitor drugs can reduce the risk of BRCA- and HRDS-associated ovarian cancer by 70%. New research at UT Southwestern Medical Center may help expand treatment to more patients.
Cancer death rates have dropped nearly 30% since 1991, and more that 2% between 2016 and 2017 alone – the biggest one-year drop on record. The driver has been precision medicine, an approach that focuses on personalization and collaboration. Learn more now.
